Graduate CTDP Intern (Spring) at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Internship, Entry Level & New GradExperience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Enrolled in a graduate program with a concentration in Biology, Chemistry, Biochemistry, Pharmaceutical Sciences, or a related discipline
  • Students must have at least one academic term remaining following the completion of the internship

Responsibilities

  • Clinical Trial Planning and Design
  • Clinical Trial Investigator Selection and Oversight
  • Patient Recruitment and Enrollment
  • Clinical Diagnostic and Laboratory Science
  • Clinical Statistics, Data Analysis & Data Management
  • Clinical Systems Management
  • Medical Writing, Communication and Documentation
  • Clinical Supply and Delivery
  • Clinical Trial Budgeting and Financial Management
  • Clinical Research Training and Education

Skills

Biology
Chemistry
Biochemistry
Pharmaceutical Sciences
Clinical Trial Planning
Clinical Trial Design
Patient Recruitment
Clinical Statistics
Data Analysis
Data Management
Clinical Systems Management
Medical Writing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI